简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-10-16 09:22 Medisca Takes Additional Steps to Protect Its Innovative Technologies
2023-10-16 09:14 Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
2023-10-13 19:36 Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
2023-10-13 09:14 FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
2023-10-13 08:55 AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge
2023-10-13 08:43 AI Medical Service Inc. Signs Joint Research Agreement with Leading Vietnamese Medical Institution
2023-10-12 15:19 Immetas Therapeutics and GC Biopharma Announce Research Collaboration to Discover and Develop mRNA Therapeutics to Treat Autoimmune Diseases
2023-10-12 11:00 Empowering Colombia's Future Through Education; ADFD's Commitment to Colombia's Early Childhood Development
2023-10-12 10:22 Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action in Atopic Dermatitis and Prurigo Nodularis
2023-10-12 08:59 SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
2023-10-12 08:52 Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China
2023-10-11 14:55 Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
2023-10-11 08:44 Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
2023-10-10 14:40 Merck Presents New MAVENCLAD® (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
2023-10-10 14:09 FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System
2023-10-10 13:28 Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
2023-10-08 16:09 Phase III Studies to Investigate Survodutide for People Living with Obesity and Overweight, with and without Diabetes, Cardiovascular Disease and Chronic Kidney Disease
2023-10-08 14:13 Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years
2023-10-08 10:34 RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
2023-10-07 16:11 Takeda Provides Update on EXKIVITY® (mobocertinib)

Business Wire Weibo

Press Releases

Latest Releases